Advertisement
Singapore markets close in 4 hours 55 minutes
  • Straits Times Index

    3,297.86
    +25.14 (+0.77%)
     
  • Nikkei

    38,393.70
    +841.54 (+2.24%)
     
  • Hang Seng

    17,081.54
    +252.61 (+1.50%)
     
  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     
  • Bitcoin USD

    66,641.05
    +95.69 (+0.14%)
     
  • CMC Crypto 200

    1,435.29
    +20.53 (+1.45%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • Dow

    38,503.69
    +263.71 (+0.69%)
     
  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     
  • Gold

    2,340.10
    -2.00 (-0.09%)
     
  • Crude Oil

    83.45
    +0.09 (+0.11%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • FTSE Bursa Malaysia

    1,568.90
    +7.26 (+0.46%)
     
  • Jakarta Composite Index

    7,179.91
    +69.09 (+0.97%)
     
  • PSE Index

    6,569.23
    +62.43 (+0.96%)
     

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Most smaller biotech companies would love to follow in the footsteps of Vertex Pharmaceuticals (NASDAQ: VRTX). Let's turn to a smaller biotech that Vertex knows very well: CRISPR Therapeutics (NASDAQ: CRSP). The two companies are partners in a blood disorders program and recently submitted their treatment candidate for regulatory approval.